20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is CAPECITABINE USP, with a corresponding US DMF Number 22479.
Remarkably, this DMF maintains an Active status since its submission on January 30, 2009, highlighting commitment to regulatory compliance.